NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Subjects United States Remove constraint Subjects: United States

Search Results

8171. Extending expiration dates of doxycycline tablets and capsules in strategic stockpiles: guidance for government public health and emergency response stakeholders

8172. Class II special controls guideline: in vitro diagnostic devices for Bacillus spp. detection : guideline for industry and Food and Drug Administration staff

8173. 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff

8174. Unique device identification: convenience kits : guidance for industry and Food and Drug Administration staff

8175. Requests for feedback and meetings for medical device submissions: the Q-Submission Program : guidance for industry and Food and Drug Administration staff

8176. Utilizing animal studies to evaluate organ preservation devices: guidance for industry and Food and Drug Administration staff

8177. Medical x-ray imaging devices conformance: guidance for industry and Food and Drug Administration staff

8178. Policy clarification for certain fluoroscopic equipment requirements: guidance for industry and Food and Drug Administration staff

8179. Laser products: conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 : (Laser Notice No. 56) : guidance for industry and Food and Drug Administration staff

8180. Classification and requirements for laser illuminated projectors (LIPs): (Laser Notice No. 57) : guidance for industry and Food and Drug Administration staff